Back to top
more

VERADIGM INC (MDRX)

(Delayed Data from OTC)

$4.80 USD

4.80
1,810

0.00 (0.00%)

Updated Jun 18, 2026 03:08 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (152 out of 247)

Industry: Medical Info Systems

Zacks News

Zacks Equity Research

Cerner (CERN) Strong on EHR Prospects, Competition Intense

Cerner's (CERN) strong EHR prospects and global outlook aid the company; margins continue to decline.

    Zacks Equity Research

    Allscripts' Payerpath & ePrescribe Receive EHNAC Accreditation

    Accreditation by EHNAC indicates Allscripts' (MDRX) sustainability in health data processing and transactions in terms of industry-established standards and HIPAA regulations.

      Zacks Equity Research

      Allscripts Sunrise Picked by UK's Maidstone and Tunbridge Wells

      Allscripts' (MDRX) Sunrise platform witnesses a suite of developments, fortifying the company's global foothold.

        Zacks Equity Research

        Allscripts Gains From Strong Results in Q2, Competition Rife

        Allscripts (MDRX) continues to gain from solid Q2 results and EHR developments; a competitive industry is a concern.

          Zacks Equity Research

          Allscripts (MDRX) Q2 Earnings In Line, Revenues Top Estimates

          Allscripts (MDRX) gains from solid segmental performance in Q2; a decline in bookings discourages.

            Zacks Equity Research

            AllScripts Healthcare (MDRX) Matches Q2 Earnings Estimates

            AllScripts (MDRX) delivered earnings and revenue surprises of 0.00% and 0.07%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

              Zacks Equity Research

              Why Is Allscripts Healthcare (MDRX) Up 9.8% Since Its Last Earnings Report?

              Allscripts Healthcare (MDRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                Zacks Equity Research

                Allscripts' iPro Anesthesia to be Administered by SingHealth

                Allscripts (MDRX) goes global, joining hands with Singapore-based hospital to implement iPro Anesthesia.

                  Zacks Equity Research

                  Allscripts Acquires HealthGrid to Improve Patient Outcome

                  Allscripts' (MDRX) HealthGrid buyout to drive FollowMyHealth platform.

                    Zacks Equity Research

                    Allscripts (MDRX) Q1 Earnings & Revenues Lag, Bookings Rise

                    Allscripts (MDRX) witnesses strong segmental performances; a solid guidance encourages.